Lykan Bioscience
Kristin M. Melocik is currently the Director at Lykan Bioscience. Prior to their current position, they worked as a Mergers & Acquisitions Investment Banking Analyst at Wells Fargo Securities from June 2015 to June 2017. Before that, they were a Mergers & Acquisitions Investment Banking Summer Analyst at Wells Fargo Securities from June 2014 to August 2014.
Kristin M. Melocik has a Master's degree in Finance from the University of Florida and a Bachelor of Science in Finance with an Accounting Minor from the University of Florida.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Lykan Bioscience
Lykan combines decades of industry experience with a drive to save lives. Lykan's goal is to provide the first true end-to-end solution in cell and gene manufacturing; ushering in a new era in the industry.